Quest Partners LLC Acquires 424 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Quest Partners LLC raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2,826.7% during the second quarter, HoldingsChannel.com reports. The fund owned 439 shares of the company’s stock after purchasing an additional 424 shares during the period. Quest Partners LLC’s holdings in Prestige Consumer Healthcare were worth $30,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of PBH. Principal Securities Inc. acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $29,000. Vanguard Personalized Indexing Management LLC bought a new position in Prestige Consumer Healthcare in the fourth quarter valued at about $222,000. Quadrant Capital Group LLC boosted its stake in shares of Prestige Consumer Healthcare by 29.3% during the fourth quarter. Quadrant Capital Group LLC now owns 1,660 shares of the company’s stock valued at $102,000 after purchasing an additional 376 shares in the last quarter. Norges Bank bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth about $27,739,000. Finally, UBS Group AG increased its stake in shares of Prestige Consumer Healthcare by 377.6% in the fourth quarter. UBS Group AG now owns 131,382 shares of the company’s stock valued at $8,043,000 after buying an additional 103,872 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Down 1.2 %

NYSE:PBH opened at $73.01 on Friday. Prestige Consumer Healthcare Inc. has a 52 week low of $56.34 and a 52 week high of $75.80. The firm’s fifty day moving average is $71.22 and its 200-day moving average is $69.67. The firm has a market cap of $3.62 billion, a P/E ratio of 17.51, a P/E/G ratio of 2.08 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.06 earnings per share. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $98.75.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.